Hosted on MSN

ArriVent Reports Promising Results for Firmonertinib in Lung Cancer Patients With Rare EGFR Mutations

NEWTOWN SQUARE, PA – ArriVent BioPharma, Inc. (Nasdaq: AVBP) presented final proof-of-concept results from its global Phase 1b FURTHER trial of firmonertinib, an oral targeted therapy for patients ...
Amazon S3 on MSN

MV-22Bs & F-35Bs • Flight Ops On USS Wasp (April 2019)

U.S. Marine Corps MV-22B Osprey tiltrotors and F35B Lightning II Joint Strike Fighters conduct flight operations aboard the USS Wasp (LHD-1) in the Philippine Sea, as part of exercise Balikatan 2019 ...